What is the main business of Advanced Biocomponents Poland?

The main business activity of Advanced Biocomponents Poland focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 1, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Chocimska 4, 00-791 Warszawa.

What is the share capital?

The share capital of the company is PLN 200,000 (approx. $54,025).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $243,933 in 2024, which is a decrease of 16.0% compared to 2023.

No, the company recorded a net loss of $76,454 in 2024. For comparison, in 2023 the loss was $8,747, meaning the company increased its loss by 730.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $243,906 in 2024, representing 77% of all operating expenses.

Advanced Biocomponents Polandsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-10-01

Share capital

200,000.00 PLN

Registered address

ul. Chocimska 4, 00-791 Warszawa, Poland

Electronic delivery address

AE:PL-78643-51379-TEHCE-25

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 487 days for 2020).

2025not filed
202425/09/2025
202325/09/2025
202219/03/2024
202110/02/2023
202014/02/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Research and experimental development on biotechnology109 / 386

Top 28%

Division · Scientific research and development617 / 1,953

Top 32%

Sector · Professional, scientific and technical activities11,465 / 39,213

Top 29%

Voivodeship · Mazowieckie61,689 / 142,033

Top 43%

Country · Poland223,858 / 495,860

Top 45%

Results vs industry

Revenue

This companyUSD 243.93kMedianUSD 55.24kAverageUSD 2.70m

Net profit

This companyUSD -76.45kMedianUSD -1.27kAverageUSD -92.18k

Operating costs

This companyUSD 315.81kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 255.91kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Edmund Puzio – President of the Management Board

Manner of representation

The following are authorised to submit declarations of will and sign on behalf of the company: 1. the President of the Management Board – independently; 2. two members of the management board acting jointly, or; 3. a member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Bioeton Deutschland Gmbh	4,000	$54,024.85	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2013-04-27.

Bank spółdzielczy
64 8838 0005 2018 0990 8972 0003
Bank spółdzielczy
21 8838 0005 2018 0990 8972 0001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Proper Medical Writingsp. z o.o.	$464,661.64	propermedicalwriting.com
Medicofarma BiotechS.A.	$314,882.33	medicofarmabiotech.pl
Explorna Therapeuticssp. z o.o.	$304,662.00	explorna.com
Frontline BiosciencesS.A.	$219,186.29	frontlinebiosciences.com
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
ModicaP.S.A.	$103,400.72	modica.bio
WPD Pharmaceuticalssp. z o.o.	$90,822.78	wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Stenocoatsp. z o.o.	$36,665.21	stenocoat.com
Platforma Badań Genetycznychsp. z o.o.	$28,558.39	zdrowegeny.pl